St. Elizabeth Healthcare Is anxiety a mood disorder or is it a physical reaction to emotional stress? The answer is that it ...

AbbVie has returned to the source of its antipsychotic powerhouse Vraylar in search of another blockbuster, paying $25 ...

NORTH CHICAGO, IL, USA and BUDAPEST, Hungary I4, 2024 I AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, ...

N-nitroso-duloxetine belongs to the nitrosamine class of compounds, some of which are classified as probable or possible human carcinogens.

A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.

AbbVie (ABBV) and Gedeon Richter announced a new discovery, co-development and license agreement to advance novel targets for the potential ...

Anxiety and depression are more common among people with Crohn’s disease, and they can worsen symptoms. Here’s why and ways ...

We are delighted to welcome Dr. Barbato to Incannex as our Chief Medical Officer. With an established track record in directing drug development through late-stage clinical trials and multiple product ...

Most of us have experienced anxiety or will at some point in the future. It's normal to feel worried from time to time.

A prescription digital therapeutic for insomnia was associated with significant improvements in sleep, depression, and anxiety.

Global Cannabis Use Disorder Treatment Market. The global cannabis use disorder treatment market is expected to grow from USD ...